$CDNA

COURNOYER CHRISTINE sold $751K of CDNA

COURNOYER CHRISTINE sold 16,000 shares of CareDx, Inc. (CDNA) at $46.94 ($0.75M total) on 2026-08-04 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · COURNOYER CHRISTINE
Published Aug 6, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 7, 2026, 7:41 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CDNA
Neutral
high confidence
Mentioned
$CDNA
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CDNANeutralLow
01

Why it matters

The newest fact is the director’s sale size, price, and total proceeds, executed on 2026-08-04 and reported on 2026-08-06.

02

Market read

This is a routine insider sale disclosure with no accompanying operational or guidance update.

03

What to watch

Traders may overreact to insider sales; the key missing detail is whether other insiders or the company simultaneously disclosed new fundamentals, which this filing does not provide.

Relevance 4/10Novelty 3/10Timing: filed 2026-08-06, sale dated 2026-08-04

Background

The article is an SEC Form 4 insider transaction disclosure for CareDx, Inc. (CDNA).

Company-level read

Ticker impact

$CDNANeutralHigh confidence
Context

CareDx director COURNOYER CHRISTINE sold 16,000 shares of CDNA for about $750,973 under a pre-arranged 10b5-1 plan.

Expected impact

Limited immediate impact expected; any effect is likely sentiment-only and short-lived.

Evidence & confidence

The filing is a routine Form 4 insider sale with stated 10b5-1 pre-arrangement, and it does not include new company operating or financial information.

Market effects

No clear sector read-through from a single director 10b5-1 sale.

None indicated.

None indicated.

Counterpoint

Because the sale is pre-arranged under 10b5-1, it may reflect scheduled liquidity needs rather than bearish expectations.

Key entities

  • CareDx, Inc.

    Company whose shares were sold by a director under a 10b5-1 plan.

  • COURNOYER CHRISTINE

    Director who sold 16,000 shares of CDNA at $46.9358 per share.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CDNAMed

CareDx (CDNA) Stock Jumps 13.0%: Will It Continue to Soar?

CareDx (CDNA) shares rose 13% to $61.37 on high volume, following a price target increase to $74 by BTIG. Q2 2026 revenue grew 52% YoY, with testing services up 61%. Q3 earnings are expected at $0.24 per share, down 14.3% YoY, and revenue at $122.35M, up 22.3% YoY. The stock has a Zacks Rank of #2 (Buy). Charles River Laboratories (CRL), another medical services company, closed up 6.2% at $294.44, with a Zacks Rank of #2 (Buy).